Ledger.Open graph →
SEC Form D · filed December 4, 2019

Clearside Biomedical, Inc

Offering
$3.3M
Sold
$3.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ALPHARETTA, 2Q
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

George Lasezkay · Alpharetta, GAExec · DirectorClay B. Thorp · Durham, NCDirectorChristy L. Shaffer · Redwood City, CADirectorCharles A. Deignan · Alpharetta, GAExecWilliam D. Humphries · Alpharetta, GADirectorJeffrey L. Edwards · Alpharetta, GADirectorRichard D. Croarkin · Alpharetta, GADirectorGeorge Lasezkay · Alpharetta, GAExec · DirectorCharles A. Deignan · Alpharetta, GAExecWilliam D. Humphries · Greensboro, NCDirectorClay B. Thorp · Durham, NCDirectorJeffrey L. Edwards · Alpharetta, GADirectorChristy L. Shaffer · CHAPEL HILL, NCDirectorRichard D. Croarkin · Alpharetta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗